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Abstract
Here, we report a straightforward synthesis process to produce colloidal Eu
3+-activated nanophosphors (NPs) for
use as bioimaging probes. In this procedure, poly(ethylene glycol) serves as a high-boiling point solvent allowing
for nanoscale particle formation as well as a convenient medium for solvent exchange and subsequent surface
modification. The La(OH)3:Eu
3+ NPs produced by this process were ~3.5 nm in diameter as determined by
transmission electron microscopy. The NP surface was coated with aminopropyltriethoxysilane to provide chemical
functionality for attachment of biological ligands, improve chemical stability and prevent surface quenching of
luminescent centers. Photoluminescence spectroscopy of the NPs displayed emission peaks at 597 and 615 nm
(lex = 280 nm). The red emission, due to
5D0 ®
7F1 and
5D0 ®
7F2 transitions, was linear with concentration as
observed by imaging with a conventional bioimaging system. To demonstrate the feasibility of these NPs to serve
as optical probes in biological applications, an in vitro experiment was performed with HeLa cells. NP emission was
observed in the cells by fluorescence microscopy. In addition, the NPs displayed no cytotoxicity over the course of
a 48-h MTT cell viability assay. These results suggest that La(OH)3:Eu
3+ NPs possess the potential to serve as a
luminescent bioimaging probe.
Introduction
Lanthanide-doped phosphors have been investigated
and employed in a broad range of technological appli-
cations such as solar energy converters, fluorescent
lighting and high-performance displays [1,2]. Recently,
nanophosphors (NPs) have received significant atten-
tion for use in biological sensing [3-5] and imaging
applications [6,7] due to their unique physical and
optical properties. As fluorescent probes, similar to
semiconductor quantum dots (QDs), these luminescent
NPs offer several advantages over conventional organic
fluorophores, including high photochemical stability,
large Stokes shift and tunable fluorescence emission
[8]. In addition, these rare-earth-based nanoparticles
exhibit several distinct and useful characteristics for
monitoring molecular and biological interactions [8,9].
Newly developed NPs exhibit long fluorescence life-
times, no photoblinking and lower cytotoxicity, which
make them attractive alternatives to QDs.
The unique photophysical properties of trivalent
lanthanide (Ln
3+) ions, which act as luminescence
activators in these NPs, result from electronic transi-
tions within the 4f shell. Electrons in these 4f orbitals
are shielded from interaction with the chemical environ-
ment by the 5s and 5p shells, which are lower in energy,
but spacially located outside of the 4f orbitals [10]. This
unique electronic configuration gives rise to emission
spectra that are characterized by sharp peaks, whose
spectral positions are independent of their matrix. How-
ever, host materials play a critical role influencing the
fine structure and emission intensities by absorbing
excitation light and transferring energy to the Ln
3+ ions.
In addition, this matrix can reduce non-radiative relaxa-
tion, such as the O–H vibration of water, which results
in luminescence quenching [11,12]. Lanthanide chelates
that bind Ln
3+ ions and incorporate organic chromo-
phores, which serve as antenna or sensitizers, have been
developed as bioprobes for time-resolved luminescent
(TRL) immunoassays and Forster resonant energy trans-
fer (FRET) experiments [13-15]. Although versatile,
these organic complexes are subject to photochemical
degradation, which remains a major challenge in the
development of these biological probes.
In response to a growing demand for more sensitive
and robust fluorescence bioimaging agents, inorganic
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3+-doped NPs composed of rare-earth oxides, oxysul-
fides, phosphates and fluorides are currently being
actively investigated [8,9]. In these NP platforms, the
host matrices tightly bind and sensitize a variety of Ln
3+
ions allowing for a wide range of emission colors
through selection of dopants. One of the most widely
used phosphor activators is trivalent europium (Eu
3+)
due to its well-characterized emission spectrum result-
ing from
5DJ(J = 0,1,2) ®
7FJ(J = 0,1,2,3) transitions.
The use of stable Eu2O3 is limited by high cost and
poor luminescence due to strong concentration quench-
ing [16]. In order to improve Eu
3+ emission, various
rare-earth host NPs have been synthesized by modifica-
tion of conventional phosphor fabrication processes,
such as solid-state and pyrolysis reactions [17,18].
Although efficient in producing highly luminescent NPs,
these synthesis methods typically require specialized
equipment and can suffer from particle aggregation lim-
iting their use under physiological conditions. Recent
efforts to produce NPs for biological applications have
focused on colloidal synthesis methods capable of pro-
ducing dispersed water-soluble NPs. In addition, surface
modification of NPs to improve biocompatibility and
allow for conjugation of biological ligands continues to
be actively investigated [19-21].
In this study, we present a facile synthesis process to
produce ultrafine Eu
3+-doped NPs for use as luminescent
bioimaging probes. Here, lanthanum hydroxide is utilized
as a rare-earth matrix material due to its lack of inherent
luminescence [10] and straightforward conversion to oxi-
des or oxysulfides through dehydration or sulfuration
[22]. This wet chemical strategy employs a low-molecular
weight poly(ethylene glycol) (PEG) as a high-boiling
point solvent allowing for monodispersed NP formation
and in situ polymer coating. The physically adsorbed
amphililic PEG serves as a temporary barrier to particle
aggregation and allows for convenient solvent exchange
for subsequent surface modification in either aqueous or
organic solutions. Here, we demonstrate surface coating
with aminopropyltriethoxysilane (APTES) to improve
chemical stability and provide amine functional groups
for conjugation of biomolecules. As-synthesized and
APTES-coated NPs were characterized to determine
their physiochemical and photoluminescence properties.
Functionalized NPs were also evaluated as luminescent
probes in a conventional biological imaging system and
in vitro fluorescence microscopy. In addition, an initial
assessment of the biocompatibility of these NPs was per-
formed using a MTT cell viability assay.
Experimental
Materials
Lanthanum nitrate hexahydrate (La(NO3)3·6H2O), poly
(ethylene glycol) (PEG, MW 570-630), titianum (IV)
isopropoxide Ti(OPr)4 (3-aminopropyl)trimethoxysilane
(APTES), dimethyl sulfoxide (DMSO) and MTT (3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
were purchased from Sigma–Aldrich (St. Louis, MO).
Europium oxide (Eu2O3), nitric acid (HNO3)a n d
toluene were purchased from Acros Organics (Morris
Plains, NJ). Sodium hydroxide (NaOH) and 200 proof
ethanol (EtOH) were purchased from Fisher Chemical
(Fairlawn, NJ). All reagents were used without further
purification. Deionized (D.I.) water was obtained from
an ultrapure water purification system (Barnstead Nano-
pure, Thermo Scientific, Dubuque, IA). Dulbecco’s mod-
ified Eagle’s medium (DMEM), fetal bovine serum
(FBS), phosphate-buffered saline (PBS), penicillin/strep-
tomycin, TrypLE and Trypan blue were purchased from
Gibco (Invitrogen, Carlsbad, CA).
Nanophosphor Synthesis and Surface Modification
Eu
3+-doped NPs were obtained through a high-tempera-
ture precipitation in low-molecular weight PEG. Initially,
39 mg Eu2O3 was dissolved in 0.2 ml 35% HNO3 under
magnetic stirring. Then, 1.9 g La(NO3)3·6H2Ow a sd i s -
solved in 0.8 mL of D.I. water and combined with the
dissolved Eu2O3 and 40 mL of PEG. A volume of
1.0 mL of 6 M NaOH was then added dropwise under
vigorous stirring, and the mixture was heated to 140°C
for 1 h. The reaction vessel was then sealed and heated
for 3 h at 140°C. The resulting colloidal solution was
cooled to room temperature and diluted 1:10 in EtOH.
To isolate the NPs, 50-mL aliquots of the NPs mixture
were centrifuged at ~2,500 RPM for 5 min. The super-
natant was decanted to remove excess PEG and reaction
byproducts. NPs were washed twice by redispersing
them in 50 mL of EtOH followed again by centrifuga-
tion and decanting the supernatant. The particles were
then resuspended in 50 mL of anhydrous toluene. Sur-
face modification was performed with the addition of
0.5 mL APTES and 50 μLT i ( O P r ) 4,a sac a t a l y s t ,f o r
12 h at 40°C in an ultrasonic bath (Branson Ultrasonic
Corp., Danbury, CA). The coated NPs were centrifuged,
and excess APTES and Ti(OPr)4 were decanted. The
resulting NPs were purified by washing three times with
ethanol and D.I. water, respectively.
Physiochemical Characterization of Nanophosphors
Transmission electron microscopy (TEM) samples were
prepared by dipping 400-mesh copper grids (Veco, Ted
Pella, Redding, CA) in a diluted suspension of NPs in
EtOH. The grids were then dried and imaged on a JEOL
TEM1230 (Tokyo, Japan) operating at 80 kV. Digital
TEM images were acquired with a Gatan 967 (Pleasan-
ton, CA) slow scan, cooled CCD camera. Particle size
distribution was calculated using NIH ImageJ with the
particle size analyzer (PSA) macro. Powder X-ray
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samples with a PANalytical X’Pert (Almelo, Nether-
lands) diffractometer using Cu-Ka radiation (l =
1.541Å) at 40 kV and 20 mA. X-ray photoelectron spec-
troscopy (XPS) experiments were carried out using a
Surface Science Instrument S-probe spectrophotometer
(Newburyport, MA) with a monochromatized Al X-ray
source and 5 eV flood gun for charge neutralization.
X - r a ys p o ts i z ef o rt h ea c q u i s i t i o nw a sa p p r o x i m a t e l y
800 μm. Pressure in the analytical chamber during spec-
tral acquisition was less than 5 × 10
-9 Torr.
Photoluminescence Characterization of Nanophosphors
Photoluminescence characterization was performed on a
FluoroMax-4 spectrofluorometer (Horiba Scientific,
E d i s o n ,N J ) .I m a g e so fN Pe m i s s i o ni n t e n s i t ya saf u n c -
tion of concentration were obtained on a Xenogen Illu-
mina system (Caliper Life Sciences, Hopkinton, MA).
For imaging, optical phantoms were prepared over a
range of concentration in 1% agarose. Fluorescence
emission was normalized to photons per second per
centimeter squared per steradian (p/s/cm
2/sr).
In Vitro Imaging Assay
Human cervical adenocarcinoma HeLa cells were cul-
tured in DMEM supplemented with 10% FBS and 1%
penicillin/streptomycin at 37°C in a humidified atmo-
sphere with 5% CO2. Cells were grown on 75-cm
2 cell-
culture flasks with 10 mL of media that was changed
every second day. To assess the optical detection of the
NPs in a biological sample, cells were incubated with
t h eN P sa tac o n c e n t r a t i o no f1 0 0μgN P / m lf o r4ha t
37°C. Cells were then washed twice with PBS and incu-
bated with TrypLE solution (substitute for porcine tryp-
sin) for 5 min at 37°C to detach them from the flask.
Cell density was determined through staining with try-
pan blue and counting cells using a hemocytometer
with 0.9-mm
3 counting chamber. To evaluate NP fluor-
escence from bulk cell sample, 10
6 cells were fixed in
methanol at -20°C for 15 min and centrifuged to isolate
a pellet for imaging. For fluorescence microscopy, cells
preincubated with NPs, as described earlier, were seeded
on 24-mm glass cover slips and incubated for 18 h to
allow them to attach. Cells were then washed with PBS
three times and fixed in methanol at -20°C for 15 min.
The cover slips were then mounted on slides using Pro-
long Gold antifade solution with DAPI (4′,6-diamidino-
2-phenylindole) (Invitrogen, Carlsbad, CA) for cell
nuclei staining and fluorescence preservation. The slides
were examined by fluorescence microscopy using a
Leica fluorescence microscope (Wetzlar, Germany)
equipped with excitation/emission filter cubes for DAPI
and FITC (fluorescein isothiocyanate). Here, an FITC
515-nm-long-pass emission filter was used to acquire all
NP emission in the green and red spectral region.
By convention, signal collected by the DAPI and FITC
filter cubes were colored blue and green, respectively.
Cytotoxicity (MTT) Assay
Human breast adenocarcinoma MCF7 cells were cul-
tured in DMEM supplemented with 10% FBS and 1%
penicillin/streptomycin at 37°C in a humidified atmo-
sphere with 5% CO2. Cells were then cleaved with Try-
pLE and counted using a hemocytometer, as described
earlier. The cells were then seeded on 96-well plates
(5,000 cells/well) in DMEM w/o phenol red. After 12-h
incubation, cells were incubated with APTES-coated
NPs at concentrations of 0, 0.1, 1.0, 10 and 100 μg/mL
in 200 μL DMEM w/o phenol red. In addition, control
(cells only) and blank (no cells) samples were also pre-
sent on the well plates. The cells were then incubated at
37°C for 12, 24 and 48 h. Four hours before the end of
each time point, 20 μL of 12 mM MTT was added to
each well. Upon completion of the incubation, all but
25 μL of the medium was removed, and 50 μLo f
DMSO was added to each well to dissolve the formazan
crystals. The samples were then mixed thoroughly with
pipetting, and the absorbance read at 540 nm on a
microplate reader (Tecan, Mannedorf, Switzerland).
Results and Discussion
Nanophosphor Synthesis and Surface Modification
The overall NP synthesis and functionalization process
is illustrated in Figure 1. This straightforward procedure
can be carried out with general chemistry laboratory
equipment and utilizes relatively low-cost reagents. In
this study, the size and morphology of the NPs pro-
duced by this process were analyzed by TEM. As shown
in Figure 2a, NPs are roughly spherical in shape with a
mean diameter of ~3.5 nm. Measurement of particle
size with the NIH ImageJ image software package dis-
played good uniformity and narrow size distribution
(Figure 2b) of the NPs, which are significant advantages
of the synthesis procedure. The size of these NPs is on
the order of biomacromolecules, such as cell-surface
receptors or antigens, making them ideal for molecular
imaging applications. In this size range, the NPs can
also be taken up by cells via endocytotic vesicles, which
are typically 40–60 nm in diameter [23]. Furthermore,
the small size of these NPs opens the potential for in
vivo applications by overcoming the size restriction of
biological barriers [24,25] and allowing for clearance to
minimize long-term toxicity [26,27].
The structure and composition of the NPs were ana-
lyzed by X-ray characterization techniques. Powder XRD
was performed on the APTES-coated NPs (Figure 2c).
Peaks consistent with crystalline La(OH)3 were observed
(JCPDS 36-1481); however, additional peaks were also
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possibly the Eu
3+ dopant. Furthermore, the relatively
low intensity of the peaks suggests a significant amor-
phous phase is present and likely due to extensive recon-
struction at the surface of these nanoparticles.
In comparison with previous reports [28,29], the use of
PEG as a surfactant in this hydrothermal synthesis of La
(OH)3 NPs significantly reduces the overall size of the
nanostructure with a trade-off of well-defined crystal
structure. Previously, polyol synthesis methods employing
diethylene glycol to produce Y2O3:Eu
3+ and Gd2O3:Eu
3+
NPs have been reported [30]. Here, we employ PEG as a
more biologically friendly and solvent compatible reaction
medium for surface modification. Further processing by
annealing the NPs synthesized in PEG and conversion to
lanthanum oxide or lanthanum oxysulfide [31] are poten-
tial areas of optimization for this NP platform; however,
these processes are beyond the scope of this work.
To confirm the NP composition and evaluate the sur-
face modification process, both as-synthesized and
APTES-coated NPs were characterized by XPS. The
survey scan obtained from the as-synthesized NPs
(Figure 3a) confirms the primary composition of lantha-
num and oxygen with main peaks of La 3d5 and O 1s
centered at ca. 835.2 and 531.1 eV, respectively. In addi-
tion, the presence of physically adsorbed PEG in these
samples likely contributes to the prominent C 1 s peak.
The low concentration of the Eu
3+ dopant (<5 mol%) is
below the detection limit of this technique. Confirmation
of the dopant in NPs is described in the following sec-
tion. The XPS survey scan of the APTES-coated NPs
(Figure 3b) displays peaks characteristic of the amine-
bearing silane in addition to the NP matrix. Main peaks
of Si 2 s and N 1s at binding energies of 152.2 and 400.7
eV, respectively, confirm the surface functionalization of
NPs. An additional peak at 458.3 eV was identified as
titanium (Ti 2p3), which was also incorporated in the
coating from the Ti(OPr)4 catalyst [32]. The presence of
this siloxane bound coating improves the chemical stabi-
lity and protects the Eu
3+ luminescent centers that may be
located at or near the surface of the NP from quenching
by water. Furthermore, the terminal amine group serves as
a convenient linking chemistry for bioconjugation [33,34],
which is necessary for biological applications.
Nanophosphor Photoluminescence
The optical properties of the La(OH)3:Eu
3+ NPs were eval-
uated by fluorescence spectroscopy under UV excitation
in the broad Eu–O charge transfer band [35,36]. The
photoluminescence spectra of the as-synthesized NPs,
s h o w ni nF i g u r e4 a( lex = 280 nm), display typical Eu
3+
emission peaks at 597 and 615 nm due to the
5D0 ®
7F1
(magnetic-dipole) and
5D0 ®
7F2 (electronic-dipole) tran-
sitions, respectively. The emission spectra of APTES-
coated NPs, shown in Figure 4b, display the same peak
positions; however, the intensity of the 615-nm emission
relative to the
5D0 ®
7F1 is increased. The stronger
5D0 ®
7F2 transition is likely due to the migration of Eu
3+ ions to
crystalline positions in the NP lattice during aging over
Figure 1 Schematic diagram of nanophosphor synthesis in
poly(ethylene glycol) (PEG) and surface modification with
aminopropyltriethoxysilane (APTES).
Figure 2 a Nanophosphor (NP) size and morphology was evaluated by transmission electron microscopy (TEM). b Particle size
distribution of NPs as determined by TEM. c XRD pattern of the NPs.
Sun et al. Nanoscale Res Lett 2011, 6:24
http://www.nanoscalereslett.com/content/6/1/24
Page 4 of 7the surface modification process. In addition, the intensity
of emission in the red spectral region was enhanced by
surface coating, as described previously. Analysis of the
APTES-coated NP in an optical phantom (Figure 4b inset,
5 mg/mL) displayed ~44% enhancement in emission
intensity when compared to bare NPs (Figure 4a inset).
In biological imaging applications where UV radiation
can damage organic structures, blue excitation has been
employed with Eu
3+ complexes [37]. To demonstrate
the use of these NPs in a conventional bioimaging sys-
tem, optical phantoms containing various concentrations
of APTES-coated NPs (0, 0.01, 0.05, 0.1, 0.5, 1.0 mg/mL)
were analyzed in an IVIS Illumina fluorescence imaging
system (lex = 430 nm). The fluorescence intensity,
expressed in radiance, was measured and plotted as a
function of concentration (Figure 5). The NPs displayed
a linear relationship of luminescence with concentration
potentially enabling their use in biological sensing and
imaging applications.
In Vitro Cell Labeling
Fluorescence labeling and optical detection of molecular
interactions has become an indispensable tool in biol-
ogy. To demonstrate the efficacy of the amine-functio-
nalized La(OH)3:Eu
3+ NPs to serve as a luminescent
probe under biological conditions, an in vitro imaging
experiment was performed with human cervical cancer
HeLa cells. In this assay, cells were labeled with APTES-
coated NPs via charge interaction between the positive
amine terminal groups and negatively charged cell
membrane. In addition, non-specific uptake of NPs was
likely due to the high incubation concentration (100 μg/
mL) and extended incubation times (4 h). After the NP
incubation, the cells were washed, cleaved, and centri-
fuged. The resulting cell pellet containing ~ 10
6 cells
and a control sample w/o NPs were imaged with the
IVIS Illumina imaging system (Figure 6). The successful
Figure 3 XPS survey scan of a as-synthesized and b APTES-coated NPs.
Figure 4 Photoluminescence spectra of a as-synthesized NPs
and b APTES-coated NPs (lex = 280 nm). Images of optical
phantoms containing 5 mg/mL as-synthesized NPs a inset and
APTES-coated NPs, b inset (lem = 575 - 650 nm).
Figure 5 Nanophosphor emission intensity as a function of
concentration. Image of optical phantoms containing 0, 0.01, 0.05,
0.1, 0.5 and 1.0 mg/mL NP, inset.
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by the red emission in comparison with control cells.
To visualize the luminescence of these NPs on the
cellular level, La(OH)3:Eu
3+ NP labeled HeLa cells
were seeded on microscope cover slips and imaged
with a fluorescence microscope (Figure 7a–d). In this
in vitro fluorescence microscopy experiment, HeLa
cells were stained with DAPI to identify the cell
nucleus (Figure 7b, blue), while the NPs were visua-
lized with a FITC excitation (420–490 nm)/emission
(515 nm long pass) filter set (Figure 7c, green). The
emission of the probes localization in the cell cyto-
plasm, likely within the endosomal or lysosomal com-
partments, demonstrates their ability to serve as
optical imaging bioprobes. In addition, after incubation
with the NPs, no changes in cell morphology or other
visual signs of cytotoxicity were observed in the phase
contrast images (Figure 7a).
Nanophosphor Cytotoxicity
To further investigate the biocompatibility of the
APTES-coated La(OH)3:Eu
3+ NPs, these NPs were eval-
uated with human breast adenocarcinoma MCF7 cells
as a model cell line. The cells were grown for intervals
of 12, 24 and 48 h with a NP concentration range typi-
c a l l yu s e di nb i o l o g i c a la s s a y s( 0 ,0 . 1 ,1 . 0 ,1 0a n d
100 μg/mL). Cell proliferation was monitored with a
MTT assay in which the reduction of a yellow tetrazo-
lium salt in metabolically active cells forms purple for-
mazan crystals [38]. The spectroscopic quantification of
the formazan corresponds with cellular viability shown
in Figure 8a–c. In this assay, no significant cytotoxicity
Figure 6 Fluorescence images of HeLa cell pellets containing
~106 cells, control (left) and NP labeled (right), acquired with a
conventional bioimaging system (Xenogen IVIS Illumina).
Figure 7 a Phase contrast image of NP-labeled HeLa cells. b Nanophosphor emission captured by FITC long-pass emission filter, which
includes the red spectral region. c DAPI emission identifying cell nuclei. d overlay of b and c.
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during the 48 h of the experiment. These results suggest
that amine-functionalized La(OH)3:Eu
3+ NPs may poten-
tially serve as optical contrast agents for bioimaging.
Conclusions
In this study, we have developed a facile synthesis pro-
cess to produce luminescent water-soluble La(OH)3:Eu
3+
NPs for biological applications. The NPs obtained from
this process are ~ 3.5 nm in size and display optical
emission typical for Eu
3+-activated probes with
5D0 ®
7F1 and
5D0 ®
7F2 transitions. Surface functionalization
with APTES was confirmed with XPS and shown to
enhance luminescence intensity by ~ 44%. In addition,
the amine terminal groups of the APTES-coated NPs
provide reactive sites for bioconjugation. Combining the
ability to attach a variety of biological ligands with selec-
tion of Ln
3+ dopant–tuned emission, these La(OH)3 NPs
may serve as effective multiplex imaging agents for var-
ious biological assays [39]. To demonstrate the lumines-
cence of the NPs under biological conditions, an in vitro
experiment was performed with HeLa cells. NP emission
was observed in the cells by both a conventional bioima-
ging system and through fluorescence microscopy.
In addition, the NPs displayed no apparent cytotoxicity
over the course of a 48-h MTT cell viability assay mak-
ing them suitable optical probes for bioimaging
applications.
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